| Item type |
学術雑誌論文 / Journal Article(1) |
| 公開日 |
2018-05-10 |
| タイトル |
|
|
タイトル |
Impact of Distal Protection with Filter-Type Device on Long-term Outcome after Percutaneous Coronary Intervention for Acute Myocardial Infarction: Clinical Results with Filtrap®. |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| ID登録 |
|
|
ID登録 |
10.24517/00014458 |
|
ID登録タイプ |
JaLC |
| 著者 |
Teramoto, Ryota
Sakata, Kenji
Miwa, Kenji
Matsubara, Takao
Yasuda, Toshihiko
Inoue, Masaru
Okada, Hirofumi
Kanaya, Honin
Kawashiri, Masa-aki
Yamagishi, Masakazu
Hayashi, Kenshi
|
| 著者別表示 |
寺本, 了太
坂田, 憲治
川尻, 剛照
山岸, 正和
林, 研至
|
| 書誌情報 |
Journal of Atherosclerosis and Thrombosis
巻 23,
号 12,
p. 1313-1323,
発行日 2016-12-01
|
| ISSN |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
1340-3478 |
| NCID |
|
|
収録物識別子タイプ |
NCID |
|
収録物識別子 |
AA11018976 |
| DOI |
|
|
関連タイプ |
isIdenticalTo |
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
10.5551/jat.34215 |
| 出版者 |
|
|
出版者 |
Japan Atherosclerosis Society = 日本動脈硬化学会 |
| 抄録 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
Aim: Although distal embolization during percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) deteriorates cardiac function, whether distal protection (DP) can improve prognosis is still controversial. We investigated whether a filter-type DP device, Filtrap®, could improve long-term outcomes after PCI for AMI. Method: We studied 164 patients (130 men, mean age: 65.7 years) who underwent PCI. Patients were divided into two groups based on the use of Filtrap®. The occurrence of congestive heart failure (CHF) and major adverse cardiac events (MACE) defined as cardiac death, recurrent AMI, and target vessel revascularization were compared. Result: Between DP (n=53, 41 men, mean age: 65.5 years) and non-DP (n=111, 89 men, mean age: 65.8 years) groups, although there was significantly greater plaque area in the DP group than in the non-DP group, there were no significant differences in coronary reperfusion flow after PCI. Interestingly, patients with CHF in the non-DP group exhibited a higher CK level than those in the DP group. During a 2-year follow-up period, cumulative CHF was significantly lower in the DP group than in the non-DP group (log-rank p=0.018), and there was no significant difference in the MACE rate (log-rank p=0.238). The use of DP device could not predict MACE, but could predict CHF by multivariate analysis (odds ratio=0.099, 95% CI: 0.02–0.42, p=0.005). Conclusion: These results demonstrate that favorable clinical outcomes could be achieved by the filter-type DP device in AMI, particularly in patients with CHF. |
| 内容記述 |
|
|
内容記述タイプ |
Other |
|
内容記述 |
出版者照会後に全文公開 |
| 権利 |
|
|
権利情報 |
Copyright © Japan Atherosclerosis Society 日本動脈硬化学会 (CC-BY NC SA) | 本論文の著作権は日本動脈硬化学会が保持しています |
| 著者版フラグ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| 関連URI |
|
|
|
識別子タイプ |
URI |
|
|
関連識別子 |
http://www.j-athero.org/en/index.html |
| 関連URI |
|
|
|
識別子タイプ |
URI |
|
|
関連識別子 |
https://www.jstage.jst.go.jp/browse/jat |
ME-PR-YAMAGISHI-M-1313.pdf (533.4 kB)
.png)
